Issue navigation
Volume 29, Issue 4, February 2008
Editorials
Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
Hallvard Holdaas
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 425–426, https://doi.org/10.1093/eurheartj/ehm628
Factor XIII: the cement of the heart after myocardial infarction?
Davy Vanhoutte and Stephane Heymans
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 427–428, https://doi.org/10.1093/eurheartj/ehm610
Platelet glycoprotein IIb/IIIa receptor inhibitors—end of an era?
Marco Roffi and Debabrata Mukherjee
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 429–431, https://doi.org/10.1093/eurheartj/ehm624
Bicuspid aortic valve syndrome: heterogeneous but predictable?
Paul W. M. Fedak
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 432–433, https://doi.org/10.1093/eurheartj/ehm609
MR perfusion imaging. What will be its impact for detection of coronary disease in the future?
Bernhard L. Gerber
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 434–435, https://doi.org/10.1093/eurheartj/ehn030
Current opinion
New cardiovascular risk determinants do exist and are clinically useful
Yvo M. Smulders and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 436–440, https://doi.org/10.1093/eurheartj/ehm566
New cardiovascular risk factors exist, but are they clinically useful?
Thomas J. Wang
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 441–444, https://doi.org/10.1093/eurheartj/ehm644
CLINICAL VIGNETTES
Alkaptonuric aortic stenosis
Mattias Roser and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 444, https://doi.org/10.1093/eurheartj/ehm406
Clinical Research
Coronary heart disease
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction
Matthias Nahrendorf and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 445–454, https://doi.org/10.1093/eurheartj/ehm558
One-year clinical outcomes with abciximab vs. placebo in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention after pre-treatment with clopidogrel: results of the ISAR-REACT 2 randomized trial
Gjin Ndrepepa and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 455–461, https://doi.org/10.1093/eurheartj/ehm562
Interventional cardiology
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial
Gilles Montalescot and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 462–471, https://doi.org/10.1093/eurheartj/ehn008
Valvular heart disease
Aortic elasticity and size in bicuspid aortic valve syndrome
Stefano Nistri and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 472–479, https://doi.org/10.1093/eurheartj/ehm528
Imaging
MR-IMPACT: comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial
Juerg Schwitter and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 480–489, https://doi.org/10.1093/eurheartj/ehm617
CLINICAL VIGNETTES
Suppurative bacterial myocarditis: echocardiographic and pathological findings
Tania Elias and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 489, https://doi.org/10.1093/eurheartj/ehm385
Clinical Research
Imaging
Early validation study of 64-slice multidetector computed tomography for the assessment of myocardial viability and the prediction of left ventricular remodelling after acute myocardial infarction
Akira Sato and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 490–498, https://doi.org/10.1093/eurheartj/ehm630
Prevention and epidemiology
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure
Peter S. Sever and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 499–508, https://doi.org/10.1093/eurheartj/ehm583
Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community
Gillian A. Whalley and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 509–516, https://doi.org/10.1093/eurheartj/ehm647
Vascular medicine
Assessment of renal artery stenosis: side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements
Benny Drieghe and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 517–524, https://doi.org/10.1093/eurheartj/ehm631
Preclinical research
Genome-wide linkage analysis of electrocardiographic and echocardiographic left ventricular hypertrophy in families with hypertension
Bongani M. Mayosi and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 525–530, https://doi.org/10.1093/eurheartj/ehn028
SPECIAL ARTICLES
Cardiac computed tomography: indications, applications, limitations, and training requirements: Report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology
Stephen Schroeder and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 531–556, https://doi.org/10.1093/eurheartj/ehm544
Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement
Claudio Marcassa and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 557–563, https://doi.org/10.1093/eurheartj/ehm607
Letters to the Editor
Diabetic cardiomyopathy: a controversial entity
Theodoros D. Karamitsos and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 564, https://doi.org/10.1093/eurheartj/ehm590
Diabetic cardiomyopathy: a controversial entity: reply
Ewa Konduracka and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 565, https://doi.org/10.1093/eurheartj/ehm591
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia
Przemyslaw Leszek and Marcin Kruszewski
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 565–566, https://doi.org/10.1093/eurheartj/ehm598
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regiments of darbepoetin alfa in patients with heart failure and anaemia: reply
Dirk J. van Veldhuisen and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 566–567, https://doi.org/10.1093/eurheartj/ehm600
Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible?
Eftychios Siniorakis and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 567, https://doi.org/10.1093/eurheartj/ehm599
Intraoperative myocardial infarction in non-cardiac surgery: is a universal definition feasible? reply
Kristian Thygesen and others
European Heart Journal, Volume 29, Issue 4, February 2008, Pages 567–568, https://doi.org/10.1093/eurheartj/ehm601
CLINICAL VIGNETTES
A case of clover-shaped left ventricular non-compaction
Tairo Kurita and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 569, https://doi.org/10.1093/eurheartj/ehm407
Cardiac magnetic resonance and 64-slice cardiac CT of lipomatous metaplasia of chronic myocardial infarction
Jean-Francois Deux and others
European Heart Journal, Volume 29, Issue 4, February 2008, Page 570, https://doi.org/10.1093/eurheartj/ehm408
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals